Stocks Health care WHWK
NASDAQ · Health careWhitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. brought in $0 of revenue over the twelve months to June 30, 2026, down 100.0% from a year earlier. It posted a net loss of $79.8M. In fiscal 2025 capital spending exceeded operating cash flow by $98M. At June 30, 2026 it held $85.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Whitehawk Therapeutics, Inc. does
Whitehawk Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker WHWK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $7.1M | -$20.6M | -$0.33 | -$98M |
| 2024 | $26M | -$63.7M | -$2.36 | -$61.2M |
| 2023 | $24.4M | -$65.8M | -$2.44 | -$63.6M |
| 2022 | $15.2M | -$60.5M | -$2.69 | -$50.1M |
| 2021 | $14M | -$110.1M | -$12.41 | -$22.5M |
| 2020 | $14M | -$3.5M | -$1.76 | -$12.7M |
Latest SEC filings
What Whitehawk Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- June 12, 2026
- May 29, 2026
- May 21, 2026Other event 8-K
- May 18, 2026Activist stake changed SCHEDULE 13D/A
- May 14, 2026Activist stake changed SCHEDULE 13D/A
Questions about WHWK
What does Whitehawk Therapeutics, Inc. do?
Whitehawk Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker WHWK.
Is Whitehawk Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $79.8M.
How much revenue does Whitehawk Therapeutics, Inc. make?
Over the twelve months to June 30, 2026 Whitehawk Therapeutics, Inc. reported revenue of $0. That is 100.0% less than a year earlier.
When did Whitehawk Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade (amended) from September 18, 2026.
Similar companies
Follow WHWK
Get an email when Whitehawk Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow WHWK: get an email when it filesWhere the numbers come from
Financial figures are the values Whitehawk Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.